Results 251 to 260 of about 226,927 (283)
Some of the next articles are maybe not open access.

The interpretation of China national essential medicines list 2018

Expert Review of Clinical Pharmacology, 2020
Background: In 2018, China implemented the latest National Essential Medicines List (NEML) by enhancing the NEML 2012. The goal of our studies is to analyze the changes in the two lists and compared them with the 20th EML issued by WHO in 2017. And then provide suggestions for emerging problems.Method: The overall composition of the categories ...
Wei, Zuo   +6 more
openaire   +2 more sources

The Essential Medicines List for a Global Patient Population

Clinical Pharmacology & Therapeutics, 2007
Thirty years after its inception, the role, audience, and contents of the global Essential Medicines List (EML) are reviewed. Challenges for decision makers in applying the principles of medicine selection based on efficacy, safety, burden of disease, and cost effectiveness are discussed and illustrated with recent decisions of the Expert Committee ...
J, Robertson, S R, Hill
openaire   +2 more sources

Lucentis excluded from WHO list of essential medicines

BMJ, 2015
The World Health Organization has rejected an application by Novartis to include ranibizumab (Lucentis) for neovascular eye diseases in the most recent update of its essential medicines list.1 The agency has, however, included “groundbreaking” new treatments for hepatitis C, a variety of cancers (including breast cancer and leukaemia), and multidrug ...
openaire   +1 more source

Essential medicines lists are for high income countries too

BMJ, 2023
Petra, Brhlikova   +3 more
openaire   +2 more sources

The WHO fungal priority pathogens list as a game-changer

Nature Reviews Microbiology, 2023
Matthew C Fisher, David W Denning
exaly  

List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ

International Journal of Systematic and Evolutionary Microbiology, 2020
Aidan C Parte   +2 more
exaly  

WHO updates its Essential Medicines List

PharmacoEconomics & Outcomes News, 2017
openaire   +1 more source

Enhancing global access to cancer medicines

Ca-A Cancer Journal for Clinicians, 2020
Javier Cortes   +2 more
exaly  

Home - About - Disclaimer - Privacy